Lek Pharmaceuticals d.d. Salutas Pharma GmbH Synthon B.V. Synthon Hispania S.L.

Poland

All drugs from this manufacturer

  • LENALIDOMIDE SANDOZ

    The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 5 mg

    ATC: L04AX04

  • The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 10 mg

    ATC: L04AX04

  • The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 15 mg

    ATC: L04AX04

  • The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 25 mg

    ATC: L04AX04